GB0914318D0 - Method - Google Patents

Method

Info

Publication number
GB0914318D0
GB0914318D0 GB0914318A GB0914318A GB0914318D0 GB 0914318 D0 GB0914318 D0 GB 0914318D0 GB 0914318 A GB0914318 A GB 0914318A GB 0914318 A GB0914318 A GB 0914318A GB 0914318 D0 GB0914318 D0 GB 0914318D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0914318A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB0914318A priority Critical patent/GB0914318D0/en
Publication of GB0914318D0 publication Critical patent/GB0914318D0/en
Priority to PCT/GB2010/051338 priority patent/WO2011018667A1/en
Ceased legal-status Critical Current

Links

GB0914318A 2009-08-14 2009-08-14 Method Ceased GB0914318D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0914318A GB0914318D0 (en) 2009-08-14 2009-08-14 Method
PCT/GB2010/051338 WO2011018667A1 (en) 2009-08-14 2010-08-12 Endonuclease g as target for hypertension and hypertrophy associated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0914318A GB0914318D0 (en) 2009-08-14 2009-08-14 Method

Publications (1)

Publication Number Publication Date
GB0914318D0 true GB0914318D0 (en) 2009-09-30

Family

ID=41171469

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0914318A Ceased GB0914318D0 (en) 2009-08-14 2009-08-14 Method

Country Status (2)

Country Link
GB (1) GB0914318D0 (en)
WO (1) WO2011018667A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117929744B (en) * 2023-12-14 2025-01-17 福建中医药大学 Use of RAB31 inhibitors in the preparation of products for preventing and/or treating hypertension

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0786469T3 (en) 1990-06-11 2006-07-10 Gilead Sciences Inc Nucleic acid
AU2001265953B2 (en) 2000-05-12 2005-09-29 D. Collen Research Foundation Vzw Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage
CA2529917A1 (en) * 2003-06-20 2005-01-13 Arena Pharmaceuticals, Inc. Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
US20090226898A1 (en) 2005-07-14 2009-09-10 Inverness Medical Switzerland Gmbh Mitochondrial markers of ischemia
US20090234225A1 (en) 2008-01-10 2009-09-17 The Ohio State University Research Foundation Fluorescence detection system

Also Published As

Publication number Publication date
WO2011018667A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
GB0905140D0 (en) Method
GB0911905D0 (en) Method
GB201003450D0 (en) Method
GB0902476D0 (en) Method
GB0922435D0 (en) Method
GB0910707D0 (en) Method
GB0913525D0 (en) Method
GB0918940D0 (en) Method
GB0913433D0 (en) Method
GB0901444D0 (en) Method
GB0921375D0 (en) Method
GB0917457D0 (en) Method
GB0916570D0 (en) Method
GB0905367D0 (en) Method
GB0903316D0 (en) Method
GB0916013D0 (en) Method
GB0908770D0 (en) Method
GB0902034D0 (en) Method
GB0920596D0 (en) Method
GB0919901D0 (en) Method
GB0917988D0 (en) Method
GB0911362D0 (en) Method
GB0904946D0 (en) Method
GB0900560D0 (en) Method
GB0920089D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)